These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7861044)

  • 21. [Standardization of procedures of instrumentalization of the data in the prevention and treatment of physical disabilities in leprosy].
    de Oliveira S; Pedroso M; Baccarelli R; Gonçalves A
    Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(2):75-9. PubMed ID: 2135364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the WHO disability grading system for leprosy related to the level of functional activity and social participation?
    Cunha de Souza VT; Da Silva Júnior WM; Ribeiro De Jesus AM; De Oliveira DT; Raptis HA; De Freitas PHL; Schneiberg S
    Lepr Rev; 2016 Jun; 87(2):191-200. PubMed ID: 30212053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leprosy: too complex a disease for a simple elimination paradigm.
    Lockwood DN; Suneetha S
    Bull World Health Organ; 2005 Mar; 83(3):230-5. PubMed ID: 15798849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensory testing in leprosy: comparison of ballpoint pen and monofilaments.
    Koelewijn LF; Meima A; Broekhuis SM; Richardus JH; Mitchell PD; Benbow C; Saunderson PR
    Lepr Rev; 2003 Mar; 74(1):42-52. PubMed ID: 12669932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uniform MDT (U-MDT) regimen for all leprosy patients--another example of wishful thinking.
    Ji B; Saunderson P
    Lepr Rev; 2003 Mar; 74(1):2-6. PubMed ID: 12669926
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions.
    Moet FJ; Meima A; Oskam L; Richardus JH
    Lepr Rev; 2004 Dec; 75(4):310-26. PubMed ID: 15682969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?
    Burger M; Denzinger S; Wieland WF; Stief CG; Hartmann A; Zaak D
    BJU Int; 2008 Jul; 102(2):194-7. PubMed ID: 18435811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between detection delay and impairment in leprosy control: a comparison of patient cohorts from Bangladesh and Ethiopia.
    Van Veen NH; Meima A; Richardus JH
    Lepr Rev; 2006 Dec; 77(4):356-65. PubMed ID: 17343222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disability prevention and management in leprosy: a field experience.
    Ganapati R; Pai VV; Kingsley S
    Indian J Dermatol Venereol Leprol; 2003; 69(6):369-74. PubMed ID: 17642944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy.
    Sharma P; Kar HK; Beena KR; Kaur H; Narayan R
    Indian J Lepr; 1996; 68(2):127-36. PubMed ID: 8835580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future trends in the treatment of leprosy.
    Pattyn SR
    Trop Geogr Med; 1994; 46(2):85-8. PubMed ID: 8079396
    [No Abstract]   [Full Text] [Related]  

  • 32. Disability grading in leprosy. Suggested modifications to the WHO disability grading form.
    Brandsma JW; de Jong N; Tjepkema A
    Lepr Rev; 1986 Dec; 57(4):361-9. PubMed ID: 3796185
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical prediction rule for nerve function impairment in leprosy patients-revisited after 5 years of follow-up.
    Croft RP; Nicholls PG; Steyerberg EW; Richardus JH; Withington SG; Smith WC
    Lepr Rev; 2003 Mar; 74(1):35-41. PubMed ID: 12669931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disability grading systems in leprosy.
    Thappa DM
    Indian J Lepr; 1993; 65(2):244-5. PubMed ID: 8345242
    [No Abstract]   [Full Text] [Related]  

  • 35. [The "Mini-ICF-Rating for Mental Disorders (Mini-ICF-P)". A short instrument for the assessment of disabilities in mental disorders].
    Linden M; Baron S
    Rehabilitation (Stuttg); 2005 Jun; 44(3):144-51. PubMed ID: 15933950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leprosy: diagnostic and control challenges for a worldwide disease.
    Goulart IM; Goulart LR
    Arch Dermatol Res; 2008 Jul; 300(6):269-90. PubMed ID: 18461340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delay in presentation, an indicator for nerve function status at registration and for treatment outcome--the experience of the Bangladesh Acute Nerve Damage Study cohort.
    Nicholls PG; Croft RP; Richardus JH; Withington SG; Smith WC
    Lepr Rev; 2003 Dec; 74(4):349-56. PubMed ID: 14750580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leprosy control by WHO. 3. Diagnosis of leprosy].
    Saigawa K
    Repura; 1973; 42(2):173-5. PubMed ID: 4808123
    [No Abstract]   [Full Text] [Related]  

  • 39. Depressive status of leprosy patients in Bangladesh: association with self-perception of stigma.
    Tsutsumi A; Izutsu T; Akramul Islam MD; Amed JU; Nakahara S; Takagi F; Wakai S
    Lepr Rev; 2004 Mar; 75(1):57-66. PubMed ID: 15072127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of ML dipstick as a tool to classify leprosy patients.
    Buhrer-Sekula S; Sarno EN; Oskam L; Koop S; Wichers I; Nery JA; Vieira LM; de Matos HJ; Faber WR; Klatser PR
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):456-63. PubMed ID: 11332289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.